Journal of Shanghai Jiao Tong University (Medical Science) >
Application of skin autofluorescence detection technique to diagnosis of diseases
Received date: 2020-08-24
Online published: 2021-02-28
Supported by
National Natural Science Foundation of China(81772098);Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20152227);Outstanding Professional and Technical Leader Program of Shanghai Municipal Science and Technology Commission(18XD1423700)
Skin is the largest organ of human body. Its histological changes may reflect local lesions and serve as the manifestation of systemic diseases. Some molecules in the skin can absorb exciting light of a specific wavelength and emit emission light with a longer wavelength. These molecules are called endogenous fluorophores, and the emission light is called skin autofluorescence (SAF). Different endogenous fluorophore has its specific fluorescence spectrum. When the skin undergoes pathological changes, the content of certain endogenous fluorophores in the skin will change, and even new endogenous fluorophores will be produced. SAF detection technique is a non-invasive, convenient and low-cost optical measurement without toxic side effects, which contains autofluorescence imaging and autofluorescence spectroscopy. It plays a vital and distinctive role in the diagnosis and differential diagnosis of various skin diseases and evaluation of skin pathological changes by analyzing the fluorescence intensity and the excitation or emission spectrum of skin endogenous fluorophores, especially in the early diagnosis of the disease and long-term follow-up after treatment. So far, SAF technology has been used in differential diagnosis of psoriasis, atopic dermatitis, contact dermatitis and other types of inflammatory dermatosis, in monitoring the treatment effect, quantitatively evaluating skin wound healing and scar fibrosis and predicting the type of scar formation, in quantifying and calibrating skin aging and photoaging, in differential diagnosis of multiple types of benign or malignant skin tumors, in guidance of the scope of resection in surgical operations, etc. In addition, SAF produced by advanced glycation end products can also be used as one of the risk grading indicators for various system diseases such as endocrine system, nervous system, cardiovascular system, and urinary system. This article briefly introduces the principle of SAF detection techique, reviews the application of SAF technology to the diagnosis of diseases, supplements the application of other systemic diseases and provides an outlook on the future development of SAF detection technique, in order to provide reference for related medical fields.
Lin-xiu-mei GUO , Yi-xin ZHANG . Application of skin autofluorescence detection technique to diagnosis of diseases[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2021 , 41(2) : 251 -256 . DOI: 10.3969/j.issn.1674-8115.2021.02.020
| 1 | Gravitz L. Skin[J]. Nature, 2018, 563(7732): S83. |
| 2 | Dainichi T, Kitoh A, Otsuka A, et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis[J]. Nat Immunol, 2018, 19(12): 1286-1298. |
| 3 | Giovannacci I, Magnoni C, Vescovi P, et al. Which are the main fluorophores in skin and oral mucosa? a review with emphasis on clinical applications of tissue autofluorescence[J]. Arch Oral Biol, 2019, 105: 89-98. |
| 4 | Franco W, Gutierrez-Herrera E, Kollias N, et al. Review of applications of fluorescence excitation spectroscopy to dermatology[J]. Br J Dermatol, 2016, 174(3): 499-504. |
| 5 | Sticherling M. Psoriasis and autoimmunity[J]. Autoimmun Rev, 2016, 15(12): 1167-1170. |
| 6 | Rendon A, Sch?kel K. Psoriasis pathogenesis and treatment[J]. Int J Mol Sci, 2019, 20(6): 1475. |
| 7 | Bissonnette R, Zeng H, McLean DI, et al. Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin Ⅸ[J]. J Invest Dermatol, 1998, 111(4): 586-591. |
| 8 | Wang B, Xu YT, Zhang L, et al. Protoporphyrin Ⅸ fluorescence as potential indicator of psoriasis severity and progression[J]. Photodiagnosis Photodyn Ther, 2017, 19: 304-307. |
| 9 | Nutten S. Atopic dermatitis: global epidemiology and risk factors[J]. Ann Nutr Metab, 2015, 66(): 8-16. |
| 10 | Bozek A, Zajac M, Krupka M. Atopic dermatitis and psoriasis as overlapping syndromes[J]. Mediators Inflamm, 2020, 2020: 7527859. |
| 11 | Barrett M, Luu M. Differential diagnosis of atopic dermatitis[J]. Immunol Allergy Clin North Am, 2017, 37(1): 11-34. |
| 12 | Yim JH, Jeong KH, Shin MK. Comparative study of skin autofluorescence expression in atopic dermatitis and psoriasis: a prospective in vivo study[J]. Skin Res Technol, 2017, 23(2): 169-175. |
| 13 | Agner T. Biomarkers in contact dermatitis[J]. Br J Dermatol, 2017, 176(6): 1434-1435. |
| 14 | Shin EJ, Gwak MJ, Jeong KH, et al. Lack of differentiation of allergic and irritant reactions by skin autofluorescence[J]. Contact Dermatitis, 2017, 76(5): 318-321. |
| 15 | Shin EJ, Seo JK, Lee EJ, et al. Diagnostic utility of skin autofluorescence when patch test results are doubtful[J]. Skin Res Technol, 2019, 25(1):96-99. |
| 16 | Rodrigues M, Kosaric N, Bonham CA, et al. Wound healing: a cellular perspective[J]. Physiol Rev, 2019, 99(1): 665-706. |
| 17 | Deka G, Wu WW, Kao FJ. In vivo wound healing diagnosis with second harmonic and fluorescence lifetime imaging[J]. J Biomed Opt, 2013, 18(6): 061222. |
| 18 | Wang Y, Gutierrez-Herrera E, Ortega-Martinez A, et al. UV fluorescence excitation imaging of healing of wounds in skin: evaluation of wound closure in organ culture model[J]. Lasers Surg Med, 2016, 48(7): 678-685. |
| 19 | Zhao HL, Zhang CP, Zhu H, et al. Autofluorescence of collagen fibres in scar[J]. Skin Res Technol, 2017, 23(4): 588-592. |
| 20 | Viktoriya A, Irina R, Anastasiia G, et al. Laser fluorescence spectroscopy in predicting the formation of a keloid scar: preliminary results and the role of lipopigments[J]. Biomed Opt Express, 2020, 11(4): 1742-1751. |
| 21 | Kohl E, Steinbauer J, Landthaler M, et al. Skin ageing[J]. J Eur Acad Dermatol Venereol, 2011, 25(8): 873-884. |
| 22 | Rittié L, Fisher GJ. Natural and sun-induced aging of human skin[J]. Cold Spring Harb Perspect Med, 2015, 5(1): a015370. |
| 23 | Kollias N, Gillies R, Moran M, et al. Endogenous skin fluorescence includes bands that may serve as quantitative markers of aging and photoaging[J]. J Invest Dermatol, 1998, 111(5): 776-780. |
| 24 | Na R, Stender IM, Henriksen M, et al. Autofluorescence of human skin is age-related after correction for skin pigmentation and redness[J]. J Invest Dermatol, 2001, 116(4): 536-540. |
| 25 | Gillies R, Zonios G, Anderson RR, et al. Fluorescence excitation spectroscopy provides information about human skin in vivo[J]. J Invest Dermatol, 2000, 115(4): 704-707. |
| 26 | Sandby-M?ller J, Thieden E, Philipsen PA, et al. Skin autofluorescence as a biological UVR dosimeter[J]. Photodermatol Photoimmunol Photomed, 2004, 20(1): 33-40. |
| 27 | Togsverd-Bo K, Philipsen PA, H?dersdal M, et al. Skin autofluorescence reflects individual seasonal UV exposure, skin photodamage and skin cancer development in organ transplant recipients[J]. J Photochem Photobiol B, 2018, 178: 577-583. |
| 28 | Tyrrell J, Paterson C, Curnow A. Regression analysis of protoporphyrin Ⅸ measurements obtained during dermatological photodynamic therapy[J]. Cancers (Basel), 2019, 11(1): 72. |
| 29 | Na R, Stender IM, Wulf HC. Can autofluorescence demarcate basal cell carcinoma from normal skin? a comparison with protoporphyrin Ⅸ fluorescence[J]. Acta Derm Venereol, 2001, 81(4): 246-249. |
| 30 | Brancaleon L, Durkin AJ, Tu JH, et al. In vivo fluorescence spectroscopy of nonmelanoma skin cancer[J]. Photochem Photobiol, 2001, 73(2): 178-183. |
| 31 | Panjehpour M, Julius CE, Phan MN, et al. Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers[J]. Lasers Surg Med, 2002, 31(5): 367-373. |
| 32 | Maciel VH, Correr WR, Kurachi C, et al. Fluorescence spectroscopy as a tool to in vivo discrimination of distinctive skin disorders[J]. Photodiagnosis Photodyn Ther, 2017, 19: 45-50. |
| 33 | Lihachev A, Lihacova I, Plorina EV, et al. Differentiation of seborrheic keratosis from basal cell carcinoma, nevi and melanoma by RGB autofluorescence imaging[J]. Biomed Opt Express, 2018, 9(4): 1852-1858. |
| 34 | Wang S, Zhao JH, Lui H, et al. In vivo near-infrared autofluorescence imaging of pigmented skin lesions: methods, technical improvements and preliminary clinical results[J]. Skin Res Technol, 2013, 19(1): 20-26. |
| 35 | Tamo?iūnas M, Plorina EV, Lange M, et al. Autofluorescence imaging for recurrence detection in skin cancer postoperative scars[J]. J Biophotonics, 2020, 13(3): e201900162. |
| 36 | Stenquist B, Ericson MB, Strandeberg C, et al. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery[J]. Br J Dermatol, 2006, 154(2): 305-309. |
| 37 | van der Beek N, de Leeuw J, Demmendal C, et al. PpⅨ fluorescence combined with auto-fluorescence is more accurate than PpⅨ fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study[J]. Lasers Surg Med, 2012, 44(4): 271-276. |
| 38 | Bratchenko IA, Artemyev DN, Myakinin OO, et al. Combined Raman and autofluorescence ex vivo diagnostics of skin cancer in near-infrared and visible regions[J]. J Biomed Opt, 2017, 22(2): 27005. |
| 39 | Khristoforova YA, Bratchenko IA, Myakinin OO, et al. Portable spectroscopic system for in vivo skin neoplasms diagnostics by Raman and autofluorescence analysis[J]. J Biophotonics, 2019, 12(4): e201800400. |
| 40 | Meerwaldt R, Graaff R, Oomen PHN, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation[J]. Diabetologia, 2004, 47(7): 1324-1330. |
| 41 | Da Moura Semedo C, Webb M, Waller H, et al. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations[J]. Postgrad Med J, 2017, 93(1099): 289-294. |
| 42 | Fokkens BT, van Waateringe RP, Mulder DJ, et al. Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: the lifelines cohort study[J]. Diabetes Metab, 2018, 44(5): 424-430. |
| 43 | Viramontes H?rner D, Taal MW. Skin autofluorescence: an emerging biomarker in persons with kidney disease[J]. Curr Opin Nephrol Hypertens, 2019, 28(6): 507-512. |
| 44 | Lavielle A, Rubin S, Boyer A, et al. Skin autofluorescence in acute kidney injury[J]. Crit Care, 2017, 21(1): 24. |
| 45 | Cavero-Redondo I, Soriano-Cano A, álvarez-Bueno C, et al. Skin autofluorescence-indicated advanced glycation end products as predictors of cardiovascular and all-cause mortality in high-risk subjects: a systematic review and meta-analysis[J]. J Am Heart Assoc, 2018, 7(18): e009833. |
| 46 | Igase M, Ohara M, Igase K, et al. Skin autofluorescence examination as a diagnostic tool for mild cognitive impairment in healthy people[J]. J Alzheimers Dis, 2017, 55(4): 1481-1487. |
| 47 | van Waateringe RP, Mook-Kanamori MJ, Slagter SN, et al. The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation[J]. PLoS One, 2017, 12(6): e0179330. |
| 48 | Calin MA, Parasca SV, Savastru R, et al. Optical techniques for the noninvasive diagnosis of skin cancer[J]. J Cancer Res Clin Oncol, 2013, 139(7): 1083-1104. |
| 49 | Morvová M Jr, Jeczko P, ?ikurová L. Gender differences in the fluorescence of human skin in young healthy adults[J]. Skin Res Technol, 2018, 24(4): 599-605. |
| 50 | Sandby-M?ller J, Poulsen T, Wulf HC. Influence of epidermal thickness, pigmentation and redness on skin autofluorescence[J]. Photochem Photobiol, 2003, 77(6): 616-620. |
| 51 | Papaioannou TG, Alexandraki KI, Karamanou M, et al. Association of skin autofluorescence with arterial properties: a closer look at AGE Reader and EndoPAT 2000 commercial devices[J]. Exp Gerontol, 2017, 98: 207-208. |
/
| 〈 |
|
〉 |